73 related articles for article (PubMed ID: 12211716)
1. Bcl-2 antigen expression in patients with chronic hepatitis C and advanced fibrosis.
Gabriel A; Ziółkowski A; Dziambor AP; Radłowski P; Kropczyński G
Med Sci Monit; 2001 May; 7 Suppl 1():181-4. PubMed ID: 12211716
[TBL] [Abstract][Full Text] [Related]
2. Potential role of bcl-2 and bax mRNA and protein expression in chronic hepatitis type B and C: a clinicopathologic study.
Tsamandas AC; Thomopoulos K; Zolota V; Kourelis T; Karatzas T; Ravazoula P; Tepetes K; Petsas T; Karavias D; Karatza C; Bonikos DS; Gogos C
Mod Pathol; 2003 Dec; 16(12):1273-88. PubMed ID: 14681329
[TBL] [Abstract][Full Text] [Related]
3. Expression of Bax, Bcl-xL and Bcl-2 proteins in relation to grade of inflammation and stage of fibrosis in chronic hepatitis C.
Piekarska A; Kubiak R; Omulecka A; Szymczak W; Piekarski J
Histopathology; 2007 Jun; 50(7):928-35. PubMed ID: 17543083
[TBL] [Abstract][Full Text] [Related]
4. Expression of Ki-67, transforming growth factor beta1, and B-cell lymphoma-leukemia-2 in liver tissue of patients with chronic liver diseases.
Piekarska A; Piekarski J; Omulecka A; Szymczak W; Kubiak R
J Gastroenterol Hepatol; 2006 Apr; 21(4):700-10. PubMed ID: 16677156
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2 protein expression in acute and chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Nakopoulou L; Stefanaki K; Vourlakou C; Manolaki N; Gakiopoulou H; Michalopoulos G
Pathol Res Pract; 1999; 195(1):19-24. PubMed ID: 10048090
[TBL] [Abstract][Full Text] [Related]
6. Bcl-2 positivity in B and C hepatitis and hepatocellular carcinomas.
Yildiz L; Baris S; Aydin O; Kefeli M; Kandemir B
Hepatogastroenterology; 2008; 55(88):2207-10. PubMed ID: 19260506
[TBL] [Abstract][Full Text] [Related]
7. Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury.
Walsh MJ; Vanags DM; Clouston AD; Richardson MM; Purdie DM; Jonsson JR; Powell EE
Hepatology; 2004 May; 39(5):1230-8. PubMed ID: 15122751
[TBL] [Abstract][Full Text] [Related]
8. Intrahepatic lymphocyte phenotypes in hepatitis C virus infection: a comparison between cirrhotic and non-cirrhotic livers.
Bonacini M; Govindarajan S; Kohla M; Lai MM; Lindsay KL
Minerva Gastroenterol Dietol; 2007 Mar; 53(1):1-7. PubMed ID: 17415341
[TBL] [Abstract][Full Text] [Related]
9. [Expression of Bcl-2 and Bax proteins in rat liver fibrosis model and the role of IFN-gamma].
Tao J; Cai WM; Lu LW; Chen QW; Weng HL; Zhang YS
Zhonghua Gan Zang Bing Za Zhi; 2003 Nov; 11(11):669-72. PubMed ID: 14636443
[TBL] [Abstract][Full Text] [Related]
10. Tenascin-C in chronic canine hepatitis: immunohistochemical localization and correlation with necro-inflammatory activity, fibrotic stage, and expression of alpha-smooth muscle actin, cytokeratin 7, and CD3+ cells.
Mekonnen GA; Ijzer J; Nederbragt H
Vet Pathol; 2007 Nov; 44(6):803-13. PubMed ID: 18039893
[TBL] [Abstract][Full Text] [Related]
11. The expression of bcl-2 in chronic liver diseases.
Mutluay R; Ozenirler S; Poyraz A
Saudi Med J; 2005 Aug; 26(8):1245-9. PubMed ID: 16127523
[TBL] [Abstract][Full Text] [Related]
12. Expression of bcl-2 in ductular proliferation is related to periportal hepatic stellate cell activation and fibrosis progression in patients with autoimmune cholestasis.
Sánchez-Muñoz D; Castellano-Megías VM; Romero-Gómez M
Dig Liver Dis; 2007 Mar; 39(3):262-6. PubMed ID: 17270507
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of Bcl-2 in lymphocytes infiltrating into the liver of patients with primary biliary cirrhosis.
Deguchi A; Arima K; Masaki T; Yachida M; Nakai S; Ito T; Kita Y; Kurokohchi K; Watanabe S; Kuriyama S
Int J Mol Med; 2002 Jun; 9(6):571-7. PubMed ID: 12011972
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of Fas and apoptosis in type-1 autoimmune hepatitis.
Seki S; Kitada T; Iwai S; Kadoya H; Yamada T; Kawada N; Sakaguchi H; Wakasa K
Hepatogastroenterology; 2003; 50(53):1274-7. PubMed ID: 14571717
[TBL] [Abstract][Full Text] [Related]
15. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
[TBL] [Abstract][Full Text] [Related]
16. Increased Fas and Bcl-2 expression on peripheral blood T and B lymphocytes from juvenile-onset systemic lupus erythematosus, but not from juvenile rheumatoid arthritis and juvenile dermatomyositis.
Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C
Clin Dev Immunol; 2006; 13(2-4):283-7. PubMed ID: 17162369
[TBL] [Abstract][Full Text] [Related]
17. Chronic hepatitis C in the advanced adult and elderly subjects.
Gattoni A; Parlato A; Vangieri B; Bresciani M; Petraccaro M
Minerva Gastroenterol Dietol; 2009 Jun; 55(2):145-57. PubMed ID: 19305374
[TBL] [Abstract][Full Text] [Related]
18. Correlation of hepatocyte expression of hepatitis B viral antigens with histological activity and viral titer in chronic hepatitis B virus infection: an immunohistochemical study.
Ramakrishna B; Mukhopadhya A; Kurian G
J Gastroenterol Hepatol; 2008 Nov; 23(11):1734-8. PubMed ID: 18713304
[TBL] [Abstract][Full Text] [Related]
19. Peripheral blood T, B, and NK cells in relation to histological hepatitis activity and fibrosis stage in chronic hepatitis C.
Panasiuk A; Prokopowicz D; Zak J; Wysocka J
Hepatogastroenterology; 2003; 50(49):178-82. PubMed ID: 12630018
[TBL] [Abstract][Full Text] [Related]
20. [Expression of Bcl-2 and Bax proteins in liver tissues of chronic viral hepatitis].
Xin S; Zhao J; Wang S
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Sep; 12(3):251-2. PubMed ID: 12526328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
